However, there was significant improvement in the Beck’s Depression Inventory-21 (BDI-21), World Health Organization Quality of Life-BREF (WHOQOL-BREF) score and mood-independent verbal memory, that were maintained for at least 6 weeks after the last dose of EPO (Miskowiak et al., 2014b). The gene discussed is EPO; the disease is depressive symptom measurement.